From Target to Drug: Generative Modeling for the Multimodal Structure-Based Ligand Design

Miha Škalič(Universitat Pompeu Fabra), Davide Sabbadin(Universitat Pompeu Fabra), Boris Sattarov(Universitat Pompeu Fabra), Simone Sciabola(Biogen (United States)), Gianni De Fabritiis(Institució Catalana de Recerca i Estudis Avançats)
Molecular Pharmaceutics
August 22, 2019
Cited by 139

Abstract

Chemical space is impractically large, and conventional structure-based virtual screening techniques cannot be used to simply search through the entire space to discover effective bioactive molecules. To address this shortcoming, we propose a generative adversarial network to generate, rather than search, diverse three-dimensional ligand shapes complementary to the pocket. Furthermore, we show that the generated molecule shapes can be decoded using a shape-captioning network into a sequence of SMILES enabling directly the structure-based de novo drug design. We evaluate the quality of the method by both structure- (docking) and ligand-based [quantitative structure-activity relationship (QSAR)] virtual screening methods. For both evaluation approaches, we observed enrichment compared to random sampling from initial chemical space of ZINC drug-like compounds.


Related Papers

No related papers found

Powered by citation graph analysis